Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Ariana Baio

Trump team is negotiating with weight-loss drug makers to lower prices to $149 a month: report

President Donald Trump is reportedly nearing the end of negotiations with drugmakers Eli Lilly and Novo Nordisk to offer the lowest dose of their popular obesity drugs for $149 per month in exchange for Medicare coverage for weight loss.

Preliminary details of the deal, reported by EndPoints News, indicate that Novo Nordisk, the maker of GLP-1s Ozempic and Wegovy, could offer the lowest dose of Wegovy through TrumpRx for as little as $149. In exchange, the government would extend Medicare coverage for Wegovy for weight loss purposes.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.